Skip to main content
GutCited

Serum Vitamin D Levels and Long-Term Risk of Elderly-Onset Inflammatory Bowel Disease: A Large-Scale Prospective Cohort Study.

Qian Zhang, Si Liu, Shengtao Zhu, Aifang Li, Xiujing Sun et al.
Other The American journal of medicine 2025
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D40398635'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Loại nghiên cứu
Cohort Study
Cỡ mẫu
357656
Đối tượng nghiên cứu
UK Biobank participants without IBD (mean age 57.9)
Thời gian
690 weeks
Can thiệp
Serum Vitamin D Levels and Long-Term Risk of Elderly-Onset Inflammatory Bowel Disease: A Large-Scale Prospective Cohort Study. None
Đối chứng
Vitamin D sufficiency (>=75 nmol/L)
Kết quả chính
Incident elderly-onset IBD
Xu hướng hiệu quả
Neutral
Nguy cơ sai lệch
Low

Abstract

BACKGROUND: Vitamin D is considered as a potential immunomodulator in inflammatory bowel disease development; however, emerging evidence remains inconsistent. We aimed to investigate the prospective association between serum vitamin D level and long-term risk of elderly-onset inflammatory bowel disease in a large-scale cohort. METHODS: Participants without inflammatory bowel disease at enrollment from the UK Biobank were included. Baseline blood samples were collected and serum 25-hydroxyvitamin D (25[OH]D) levels were measured. Participants were classified as having vitamin D deficiency (< 50 nmol/L), insufficiency (50-75 nmol/L) or sufficiency (≥ 75 nmol/L) based on predefined cutoffs. Primary outcome was incident elderly-onset inflammatory bowel disease, including ulcerative colitis and Crohn disease. Hazard ratio (HR) and 95% confidence intervals (CIs) of related associations were determined using multivariable Cox regression. RESULTS: Among 357,656 participants (mean age, 57.9±6.9 years), 196,499 (54.9%) and 121,035 (33.8%) had vitamin D deficiency and insufficiency, respectively. During a median 13.3 years follow-up, 1622 elderly-onset inflammatory bowel disease cases were identified. Compared with vitamin D sufficiency, no associations with vitamin D deficiency (HR = 0.91; 95% CI, 0.78-1.07) or insufficiency (HR = 0.86; 95% CI, 0.73-1.01) were observed for elderly-onset inflammatory bowel disease. Similarly, no associations with per 10 nmol/L increase of serum 25(OH)D were detected for elderly-onset inflammatory bowel disease (HR = 1.00; 95% CI, 0.98-1.03), ulcerative colitis (HR = 1.00; 95% CI, 0.97-1.03), or Crohn disease (HR = 1.01; 95% CI, 0.97-1.05). Compared with the lowest quartile, no associations with higher quartiles of serum 25(OH)D were observed for inflammatory bowel disease (HRQ4VSQ1 = 1.03; 95% CI, 0.89-1.19), ulcerative colitis (HRQ4VSQ1 = 1.06; 95% CI, 0.90-1.26), or Crohn disease (HRQ4VSQ1 = 0.93; 95% CI, 0.73-1.20). Further sensitivity and subgroup analyses demonstrated similar results. CONCLUSIONS: Serum vitamin D level or deficiency status is not associated with the development of elderly-onset inflammatory bowel disease, ulcerative colitis, or Crohn disease.

Tóm lược

Serum vitamin D level or deficiency status is not associated with the development of elderly-onset inflammatory bowel disease, ulcerative colitis or Crohn's disease, and sensitivity and subgroup analyses demonstrated similar results.

Used In Evidence Reviews

Similar Papers